Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX   12:04:55 PM EDT
+0.10 (+2.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)745.52M
Current PE70.09
Forward PE 8.15
2yr Forward PE 7.11
See more stats
Estimates Current Quarter
Revenue$504.81 Million
Adjusted EPS$0.13
See more estimates
10-Day MA$4.89
50-Day MA$4.47
200-Day MA$4.37
See more pivots

Amneal Pharmaceuticals, Inc. Stock, NYSE:AMRX

400 Crossing Boulevard, Bridgewater, NJ
United States of America
Phone: (908) 947-3120
Number of Employees: 6000


Amneal Pharmaceuticals, Inc., formerly known as Atlas Holdings, Inc. (the "Company"), was formed along with its wholly owned subsidiary, K2 Merger Sub Corporation, a Delaware corporation ("Merger Sub"), on October 4, 2017, for the purpose of facilitating the combination of Impax Laboratories, Inc. (now Impax Laboratories, LLC), a Delaware corporation then listed on the Nasdaq Stock Market ("Impax") and Amneal Pharmaceuticals LLC, a Delaware limited liability company ("Amneal").